News Center
News Center
Industry News
[2026/08/16] : Supporting the Green Global Expansion of Traditional Chemical Industries[2026/08/14] : Seven Government Departments Launch Comprehensive “Full-Chain” Crackdown on Illegal Pesticide and Veterinary Drug Activities[2026/08/13] : Xinhua Pharmaceutical: 20 Products Added to China’s 2026 National Essential Medicines List[2026/08/12] : Global Raw Material Markets Face Continued Volatility as Geopolitics and New Energy Demand Reshape Supply Chains[2026/08/10] : Anhui Biotech Leader Anke Biotechnology Accelerates Global Expansion with Innovative Drug Pipeline and International Standards[2026/08/08] : AstraZeneca–BMS Merger Talks Signal a New Wave of Pharma Consolidation: What It Means for the Veterinary API Industry[2026/08/05] : Jiangxi Biological Launches Veterinary Tetanus Antitoxin Production Line, Expanding from Human Medicine to Animal Health[2026/08/03] : Global African Swine Fever Outbreaks Escalate: Over 250,000 Pigs Affected, Highlighting the Urgency of Biosecurity and Vaccine Development[2026/07/31] : Health & Hope Accelerates Globalization Strategy Through Overseas Acquisition, Local Manufacturing and Global Supply Chain Expansion[2026/07/29] : Deyuan Pharmaceutical Advances API–Finished Dosage Integration Strategy to Strengthen Chronic Disease Drug Supply Chain[2026/07/27] : China Launches 2026 Special Campaign to Strengthen Veterinary Drug Regulation, Tightening Oversight on Veterinary Practice, Sales and Use[2026/07/25] : Sinopharm’s Hunan Subsidiaries Exit Regional Markets as China’s Pharmaceutical Distribution Industry Accelerates Restructuring[2026/07/23] : Global Veterinary Drug Regulations Continue to Tighten, Urging Chinese Exporters to Strengthen Compliance Strategies[2026/07/21] : China's API Industry Accelerates "Westward Expansion" : Mediterranean Strategy Emerges as a New Globalization Path[2026/07/19] : *China’s Lingnan Traditional Medicine Leader ST Xiangxue Faces Restructuring Hope and Investor Claim Risks[2026/07/17] : China Launches Nationwide Campaign to Strengthen Regulation of Pesticides and Veterinary Drugs[2026/07/16] : CPHI China 2026: China's Veterinary Pharma Enters a New Growth Phase[2026/07/14] : China Pharma Goes Global: The Shift from Asset Licensing to Strategic Innovation Partnerships[2026/07/12] : International Chemical Giants Announce Investment in China to Build World-Class MDI Plants, Further Strengthening Global Supply Chain Presence[2026/07/10] : Fukang Pharmaceutical's Polymyxin B Sulfate API Approved by China's NMPA
| Enter Zhuocheng | Product | Honorary Qualifications | Contact Us |
| Company IntroductionFactory Appearance | Raw materials Premixed agent product OEM products |
Company：Jinan Zhuocheng Bio-Tech Co., Ltd. Corporate email：info@zhuochengbio.com Address:Building 3, Ligao International, 1222 West Aoti Road, Lixia District, Jinan |
